CRESAR-H 40:12.5MG TABLET Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of CRESAR-H 40:12.5MG TABLET.

Available Products of CRESAR-H 40:12.5MG TABLET

CRESAR-H 40:12.5MG TABLET 14's

Reg#: 055903

Description of CRESAR-H 40:12.5MG TABLET

Telmisartan 40mg + Hydrochlorothiazide 12.5mg

Medicine Info

Pack Size: 14's

Company: Tabros Pharma (Pvt) Ltd.

Price of CRESAR-H 40:12.5MG TABLET

Price: Rs. 552.76

Related Keywords

  • CRESAR-H 40:12.5MG TABLET price in Pakistan
  • CRESAR-H 40:12.5MG TABLET tablet price
  • CRESAR-H 40:12.5MG TABLET Capsule price
  • Tabros Pharma (Pvt) Ltd. CRESAR-H 40:12.5MG TABLET price
  • Buy CRESAR-H 40:12.5MG TABLET online
  • CRESAR-H 40:12.5MG TABLET 40mg uses
  • CRESAR-H 40:12.5MG TABLET syrup price
  • CRESAR-H 40:12.5MG TABLET pack 14's cost

CRESAR-H 40:12.5MG TABLET 28's

Reg#: 055903

Description of CRESAR-H 40:12.5MG TABLET

Telmisartan 40mg + Hydrochlorothiazide 12.5mg

Medicine Info

Pack Size: 28's

Company: Tabros Pharma (Pvt) Ltd.

Price of CRESAR-H 40:12.5MG TABLET

Price: Rs. 1050.24

Related Keywords

  • CRESAR-H 40:12.5MG TABLET price in Pakistan
  • CRESAR-H 40:12.5MG TABLET tablet price
  • CRESAR-H 40:12.5MG TABLET Capsule price
  • Tabros Pharma (Pvt) Ltd. CRESAR-H 40:12.5MG TABLET price
  • Buy CRESAR-H 40:12.5MG TABLET online
  • CRESAR-H 40:12.5MG TABLET 40mg uses
  • CRESAR-H 40:12.5MG TABLET syrup price
  • CRESAR-H 40:12.5MG TABLET pack 28's cost

Alternatives brands of CRESAR-H 40:12.5MG TABLET

Explore alternative brands for CRESAR-H 40:12.5MG TABLET below.

View Alternatives

Explore More Medicines

CRESAR-H 80:12.5MG TABLET

Tabros Pharma (Pvt) Ltd.

MRP: Rs. 1979.2963

CRESAR-H 80:25MG TABLET

Tabros Pharma (Pvt) Ltd.

MRP: Rs. 1052.0287

CRESAR AM TABLET 5MG:40MG

Tabros Pharma (Pvt) Ltd.

MRP: Rs. 578.3072

CRESAR AM TABLET 10MG:40MG

Tabros Pharma (Pvt) Ltd.

MRP: Rs. 863.2647

CRESAR AM TABLET 5MG:80MG

Tabros Pharma (Pvt) Ltd.

MRP: Rs. 1106.3342

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!